GLP-1/GIP Weight Management (tirzepatide)
GLP-1/GIP Weight Management (tirzepatide)
Starting at
$499
/month- We're sorry, but to buy this product you need to complete the questionnaire
- We're sorry, but to buy this product you need to update your weight information in the questionnaire.
- you are under 18 years of age
- you are pregnant or nursing
- your BMI does not meet the required qualifications
- your BMI does not meet the required qualifications
- you reside in a currently unsupported state
- you have history of type 1 diabetes
- you have history of diabetic retinopathy
- you have history of MEN-2 disease
- you reside outside of the United States
- We're sorry, but you are not eligible for this product because you already have an active subscription for weight management product.
- We're sorry, but Qyral Weight Management products are no longer available in Mississippi.
Lose up to 26%+
Tirzepatide: In a double-blind, randomized, controlled trial, individuals who received regular tirzepatide at a dose of 15mg/week, along with following a reduced-calorie diet and increasing physical activity, experienced an average weight loss of 26% over the course of 72 weeks. Source: https://www.nature.com/articles/s41591-023-02597-w
90 day supply, billed monthly
Option to renew every 3 months
Option to cancel every 3 months
Doctor review: 1-2 days
Processing: Up to 15-20 days
(subject to pharmacy partners)
Shipping: overnight
GLP-1/GIP Weight Management (tirzepatide) includes doctor & medication with no hidden fees or insurance required
- Personalized prescription appetite suppression: Tirzepatide, a dual GLP-1 and GIP receptor agonist, is a once-weekly injection that reduces appetite and increases feelings of fullness.
- Scientifically backed weight loss aid: Tirzepatide has demonstrated significant weight loss in clinical trials, with some patients losing 26% of their body weight over 72 weeks.
- Metabolic health booster: Tirzepatide improves metabolic health by lowering blood sugar levels, improving insulin sensitivity, and lowering the risk of obesity-related health issues like type 2 diabetes, high blood pressure, and cardiovascular disease.
- Enhanced quality of life: By helping individuals reach and maintain a healthy weight, tirzepatide reduces issues like fatigue and joint pain associated with excess weight, and boosts energy levels, improving quality of life.
* The total mg of may vary depending on the pharmacy and state providing services.
** Typical patient dosing schedule. A licensed doctor will determine your final dose and schedule after your consultation.
Pricing is per month and entails a 3-month minimum commitment.
TIER 1
$499
/monthTIER 2
$849
/monthTIER 3
$899
/monthYou will be able to switch the tier every 3 months during regular assessment based on your progress and goals.
*Your dosing plan might vary based on the recommendations from a doctor on the Qyral platform. Total units in vials vary by pharmacy, you will always receive enough for the given dosing schedule.
** For patients returning to the Weight Management Program after a break, we will initiate their treatment with the initial dosing plan (Tier 1). This is a standard procedure to ensure safety and effectiveness, regardless of the dosing tier they were on before leaving the program.
Tirzepatide is a weekly injectable medication FDA-approved for the treatment of type 2 diabetes and weight management. This dual-action treatment reduces appetite and increases feelings of fullness, leveraging the mechanisms of natural hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones play key roles in regulating blood sugar and managing appetite. As a combined GLP-1 and GIP receptor agonist, tirzepatide offers an effective approach for weight loss and improving metabolic health.
Physicians on the Qyral telehealth platform may prescribe tirzepatide to support weight loss and metabolic health. The prescription may also include additional ingredients for added metabolic support. The pharmacy that will ship to you depends on your state of residence, and each pharmacy that Qyral partners with has its own unique set of metabolic support ingredients. Therefore, depending on your state, you may receive different metabolic support ingredients from the corresponding pharmacy.
Compounded tirzepatide injections are a medication that must be used with caution and under the guidance of a healthcare professional. It is important to follow a doctor's instructions regarding dosage, timing, and administration of the medication. Always read the instructions provided by the pharmacy carefully and ask any questions you may have before using the medication. It is essential to never alter the dosage or frequency of tirzepatide injections without consulting a doctor first.
FREQUENTLY ASKED QUESTIONS
Tirzepatide is used in weekly injectable medications for the treatment of type 2 diabetes and weight management.
If approved, a healthcare provider on the Qyral platform will prescribe a compounded medication containing tirzepatide, which may also include additional metabolic support ingredients. The pharmacy that will ship to you depends on your state of residence, and each pharmacy that Qyral partners with has its own unique set of metabolic support ingredients, and your licensed healthcare provider may prescribe varying components to your compounded medication. Therefore, depending on the state and the individualized assessment performed by your healthcare provider, you may receive different metabolic support ingredients from the corresponding pharmacy.
Tirzepatide for weight loss works by reducing appetite and increasing feelings of fullness. It works by mimicking the effects of the natural hormones GLP-1 and GIP in the body. These hormones help regulate appetite and blood sugar levels in the body. The medication also slows gastric emptying (how long food stays in the stomach) and can result in feeling full sooner and staying full for a longer period of time.
If approved, a provider will prescribe compounded tirzepatide. It is compounded in a pharmacy using only the highest quality ingredients. It's important to note that compounded tirzepatide is not associated with Eli Lilly and Company or the brand-name medication Mounjaro.
Choosing a compounded medication over brand-name medications can result in significant cost savings, as brand-name medications can be expensive and cost thousands of dollars. Additionally, one of the benefits of compounded pharmaceuticals is that your healthcare provider can customize the dosage specifically to your individual needs. This personalized approach can lead to more effective treatment outcomes.
Tirzepatide is generally considered safe when used as direct and under the supervision of a healthcare provider. However, like any medication, it can have potential side effects. Some common side effects of tirzepatide include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and go away over time. In rare cases, more serious side effects can occur, such as severe stomach problems or kidney problems.
It is important to talk to your healthcare provider about any potential risks and benefits of taking tirzepatide, and to report any side effects or concerns promptly.
To use tirzepatide, there are specific criteria that must be met. You must:
1. Be at least 18 years old.
2. Reside in or physically be located in one of the states where our services are available.
3. Demonstrate the need for medical treatment. If necessary, our team can assist you in obtaining recent lab results if requested by your healthcare provider.
4. Meet the FDA-approved criteria for these medications, which include having a body mass index (BMI) over 30 for individuals with obesity, and a BMI over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol.
5. Not have any of the following conditions: Type 1 Diabetes, a history of pancreatitis, severe gastrointestinal (GI) disease, current gallbladder problems (excluding previous gallbladder removal/cholecystectomy), retinal impairment/diabetic retinopathy, bariatric surgery within the past 6 months, multiple endocrine neoplasia syndrome type 2 (MEN-2), or a history of medullary thyroid cancer.
6. Not be pregnant or nursing.
A healthcare provider will make the final determination regarding your qualification for the Weight Managment Program and may request additional information from you directly.